BGM Group Ltd. (BGM) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of BGM Group Ltd. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$9.25HealthcareDelayed quote: Oct 6, 2026, 1:58 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — BGM vs OTLK
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)OTLK -92.0% (-71.6%/yr)OTLK compounded faster over this window
BGM OTLK
BGM vs OTLK: by the numbers
- •BGM is the larger company ($117M vs $107M market cap).
- •Both run net losses; BGM's is the smaller (-52.59% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | BGM | OTLK |
|---|---|---|
| P/B ratio | 0.29 | N/A |
Profitability
| Metric | BGM | OTLK |
|---|---|---|
| Gross margin | 12.79% | 46.49% |
| Operating margin | -33.18% | -4744.25% |
| Net margin | -52.59% | -4416.22% |
| ROE | -5.10% | N/A |
| ROIC | -3.19% | -352.19% |
Growth (annualized)
| Metric | BGM | OTLK |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | N/A |
| Total return CAGR (5Y) | N/A | -57.40% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.